Design and synthesis of novel antimicrobial agents
Z Breijyeh, R Karaman - Antibiotics, 2023 - mdpi.com
The necessity for the discovery of innovative antimicrobials to treat life-threatening diseases
has increased as multidrug-resistant bacteria has spread. Due to antibiotics' availability over …
has increased as multidrug-resistant bacteria has spread. Due to antibiotics' availability over …
Quality by design approach in liposomal formulations: Robust product development
Nanomedicine is an emerging field with continuous growth and differentiation. Liposomal
formulations are a major platform in nanomedicine, with more than fifteen FDA-approved …
formulations are a major platform in nanomedicine, with more than fifteen FDA-approved …
[HTML][HTML] Liposome-loaded polymeric microneedles for enhanced skin deposition of rifampicin
Methicillin-resistant Staphylococcus aureus (MRSA) is a prevailing bacterial pathogen
linked to superficial skin and soft tissue infections (SSTIs). Rifampicin (RIF), a potent …
linked to superficial skin and soft tissue infections (SSTIs). Rifampicin (RIF), a potent …
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
M Chen, Z Shou, X Jin, Y Chen - Drug Delivery, 2022 - Taylor & Francis
A boom in respiratory tract infection cases has inflicted a socio-economic burden on the
healthcare system worldwide, especially in developing countries. Limited alternative …
healthcare system worldwide, especially in developing countries. Limited alternative …
Liposomes-based drug delivery systems of anti-biofilm agents to combat bacterial biofilm formation
All currently approved antibiotics are being met by some degree of resistance by the
bacteria they target. Biofilm formation is one of the crucial enablers of bacterial resistance …
bacteria they target. Biofilm formation is one of the crucial enablers of bacterial resistance …
Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives
VK Panthi, KE Fairfull-Smith, N Islam - Journal of Drug Delivery Science …, 2024 - Elsevier
Lower respiratory tract infections (LRTIs) are inherited disorders which often causes chronic
respiratory infections for which patients repeatedly receive oral antibiotics, particularly …
respiratory infections for which patients repeatedly receive oral antibiotics, particularly …
[HTML][HTML] Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis
Cystic fibrosis (CF), a fatal genetic condition, causes thick, sticky mucus. It also causes
pancreatic dysfunction, bacterial infection, and increased salt loss. Currently available …
pancreatic dysfunction, bacterial infection, and increased salt loss. Currently available …
Overcoming barriers in cystic fibrosis therapy through inhalational lipid nanoparticles: Challenges and advances
Cystic fibrosis (CF) is a genetic disorder that follows an autosomal recessive pattern of
inheritance and is characterized by mutations in the cystic fibrosis transmembrane …
inheritance and is characterized by mutations in the cystic fibrosis transmembrane …
[PDF][PDF] Optimization and formulation of doxorubicin (DOX) loaded liposome well-used in chemotherapy involving quality by design (QbD): a transitory research
Nanomedicine is a developing discipline that is constantly evolving and differentiating.
Liposomal preparation has an important role in nanomedicine as a novel platform. QbD …
Liposomal preparation has an important role in nanomedicine as a novel platform. QbD …
Tryptone-stabilized silver nanoparticles' potential to mitigate planktonic and biofilm growth forms of Serratia marcescens
Several microbial pathogens are capable of forming biofilms. These microbial communities
pose a serious challenge to the healthcare sector as they are quite difficult to combat. Given …
pose a serious challenge to the healthcare sector as they are quite difficult to combat. Given …